Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamotrigine in BED with Obesity
NCT00277641Phase 3Completed
- Sponsor
- Lindner Center of HOPE
- Start
- Mar 2006
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in binge eating disorder (BED) comparing Lamotrigine with Placebo (2 arms). Primary endpoints: Reduction in binge eating episodes compared with baseline at 17 weeks and Safety and tolerability at 17 weeks. Started Mar 2006; status: completed.
02
Drugs
lamotrigine
03
Conditions
binge eating disorder (BED)
Beyond the preview
Go deeper on NCT00277641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00277641.